6/2/2023 0 Comments Dendrite comWith this growing client base, Baiyle boasted that Dendrite had more users of its software and service than its two largest competitors combined. The company also had offices in Japan, introducing in 1996 a state-of-the-art Windows-based system specifically designed for the Japanese market. Dendrite's client companies included such well known firms as Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly, Hoechst Marion Roussel, L'Oreal, Pfizer, and Rhone-Poulenc Rorer. By 1996, Baiyle's plans for aggressive growth were well underway with Dendrite operating out of eleven offices around the world, providing software and support services that were designed to manage, coordinate, and control large sales forces for the health care and consumer packaged goods industries. The company intended to use the proceeds for working capital, including research and development. In June 1995, Dendrite followed through on plans for going public, offering 2.6 million shares in its initial public offering. His plans also called for a growth strategy through acquisitions. contract with Pfizer, which selected the company's software for its 450-member sales force.Īggressive Growth in the Early and Mid-1990sĪlready by 1993, President and Chief Executive Officer John Baiyle saw Dendrite developing into a $100 million company in the near future and planned a public offering of common stock over the long term. In 1989, Dendrite won its first major U.S. With venture capital behind him, Baiyle expanded operations in Japan in 1988 and began opening offices in Europe in the United Kingdom, Belgium, France, Italy, Spain, and Germany. The other two investors in Dendrite included a venture fund operated by John Hancock Mutual Life Insurance Company in Boston and Brinson Partners, Inc., of Chicago. After a year of considering his options, Baiyle secured venture capital, closing on a deal with lead investor, Edison Venture Fund, for between $7 million and $10 million. As a result, Baiyle began searching for funds to buy out his partner. In 1987, Baiyle expanded the business to New Zealand and moved the company's headquarters to Warren, New Jersey, against the opposition of his corporate partner. Baiyle began the firm by designing the pharmaceutical industry's first management and marketing software for company sales forces. With its integrated sales and marketing software, Dendrite allows pharmaceutical companies to tie their sales and marketing strategies together for improved productivity.ĭendrite International was founded in 1986 by John Baiyle in Sydney, Australia, with $3 million from the sale of a former business he owned and with the help of a partner, an Australian chemical company. Dendrite's sales technology and applications enable sales forces to access product information and physician databases, assess competitors, and catalog client and prospect data. The company's solutions cover the pharmaceutical commercialization process and fit into five primary categories, including clinical development, brand marketing, customer management, sales effectiveness, and compliance management. contract with Pfizer.ġ995: Company goes public offering 2.6 million common shares.ġ998: Company surpasses $100 million revenue mark.Ģ000: Company loses Internet privacy case.Ģ001: Company appoints Paul Zaffaroni as new president and chief executive officer company opens branch office in Shanghai, China.Ģ003: Dendrite outbids rival to acquire Synavant.Ģ004: Dendrite relocates international headquarters to Bedminster, New Jersey.ĭendrite International, Inc., and its subsidiaries are leading providers of a broad array of services and software worldwide that focus on managing and analyzing sales efforts for the pharmaceutical and other life sciences industries. Our vision is to be the global leader in developing and delivering solutions that drive promotional and sales effectiveness for our pharmaceutical and other life sciences clients.ġ986: Company is founded in Sydney, Australia, by John Baiyle.ġ987: Dendrite relocates headquarters to New Jersey.ġ988: Dendrite establishes operations in Japan and Europe.ġ989: Dendrite secures first major U.S. Our tools, support skills, and knowledge facilitate more than one million contacts every day between our clients and their customers-prescribers of prescription medicines. provides leading-edge solutions & services to the global pharmaceutical industry, including the world's top 20 pharmaceutical companies, with clients in more than 50 countries. NAIC: 541510 Computer Systems Design and Related Services 541511 Custom Computer Programming Services 541512 Computer Systems Design Services 541519 Other Computer Related Servicesĭendrite International, Inc.
0 Comments
Leave a Reply. |